Paulo Rodriguez

25PUBLICATIONS
209CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 30, 2026
IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma.

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Jun 02, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

|Jan 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming.

Phaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino

|Dec 12, 2025
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment.

Hayley D Ackerman, Vanessa Y Rubio, Andrew J Davis

|Nov 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.

Xuefeng Wang, Tingyi Li, Islam Eljilany

Pageof 5

Frequent Collaborators

7 joint publications

Xuefeng Wang

6 joint publications

John M Koomen

6 joint publications

Jose R Conejo-Garcia

5 joint publications

Timothy Shaw